Skip to main content Skip to main navigation
Government logo | to homepage of National Institute for Public Health and the Environment Ministry of Health, Welfare and Sport
  • Nederlands
  • English
RIVM Committed to health and sustainability
  • Home
  • Topics
  • About RIVM
  • Publications
  • International
  • Contact
  • Agenda
  • Nederlands
  • English
  • Home
  • News

News


Search

Fill in your search phrase.

Topics

  • (-) Immunisation and vaccination (21)
  • (-) Population screening programmes (7)
  • (-) Radiation exposure in the Netherlands (1)
  • International (264)
  • COVID-19 vaccination (159)
  • COVID-19 (149)
  • National Immunisation Programme (22)
  • Antimicrobial resistance (19)
  • Tobacco (19)
  • Air (17)
  • Circular economy (17)
  • COVID-19 (14)
  • HPV vaccination (14)
  • Zoonotic diseases (14)
  • Heat (13)
  • WHO Collaborating Centre for Tobacco Product Regulation and Control (13)
  • Flu and flu vaccine (12)
  • Healthy living environment (11)
  • Nanotechnology (11)
  • One Health (11)
  • Tick bites (11)
  • WHO Collaborating Centre for Antimicrobial Resistance Epidemiology and Surveillance (11)
  • Ebola (10)
  • Food safety (10)
  • Health research for COVID-19 (10)
  • Medical devices (10)
  • WHO Collaborating Centre for Risk Assessment of Pathogens in Food and Water (10)
  • Plastics (9)
  • Nitrogen (8)
  • Sexually transmitted infections (STIs) (8)
  • Soil and water (8)
  • Tuberculosis (8)
  • Measles (7)
  • Mpox (7)
  • PFAS (7)
  • Sustainability (7)
  • Sustainable Development Goals (7)
  • WHO Collaborating Centre on Chemical Food Safety (7)
  • Food and Nutrition (6)
  • Public Health Foresight (6)
  • Salmonella (6)
  • Tick-borne encephalitis (6)
  • MERS-coronavirus (5)
  • Occupational Safety (5)
  • WHO Collaborating Centre for Nutrition (5)
  • Accidents and disasters (4)
  • Biobased economy (4)
  • Bisphenol A (BPA) (4)
  • Dutch National Food Consumption Survey (4)
  • Hydrofluorocarbons (4)
  • Rubber granulate (4)
  • Alternatives to animal testing (3)
  • Chromium (VI) and CARC (3)
  • Climate change and Health (3)
  • ConsExpo (3)
  • Heel prick (3)
  • International projects (3)
  • Legionnaires' disease (Legionellosis) (3)
  • Meningococcal ACWY (3)
  • Mosquitos (3)
  • Perinatal screening (3)
  • Pharmaceuticals in the environment (3)
  • Physical Activity (3)
  • RSV (3)
  • UV index (3)
  • West Nile fever (3)
  • Assistance RIVM Sint Maarten landfill (2)
  • CAESAR (2)
  • Cervical cancer screening programme (2)
  • Consumer exposure to chemical substances (2)
  • Dutch Food Composition Database (NEVO) (2)
  • Population screening programmes in the Caribbean Netherlands (2)
  • Beeldschermgebruik (1)
  • Breast Cancer Screening Programme (1)
  • Chikungunya (1)
  • Chikungunya (1)
  • Chroom-6 (1)
  • Dengue (1)
  • E-health (digitale zorg) (1)
  • GenX (1)
  • Health promotion (1)
  • HPV - Humaan Papillomavirus (1)
  • Leefstijlmonitor (1)
  • Lifestyle interventions (1)
  • Lifestyle Monitor: public health monitoring of lifestyle and health in the Netherlands (1)
  • Meldpunt en Expertisecentrum Bijwerkingen Implantaten (1)
  • PFAS (1)
  • PFOA (1)
  • Pneumococci (1)
  • Polio (1)
  • Rotavirus (1)
  • Screening for Down’s, Edwards’, Patau’s syndromes and ultrasound (1)
  • Sewage research (1)
  • Sustainable procurement (1)
  • Synthetic biology (1)
  • Tata Steel (Corus) (1)
  • Veilige leefomgeving (1)
  • WHO Collaborating Centre for Laboratory Preparedness and Response for High Threat Pathogens and Biorisk (1)
  • WHO Collaborating Centre on Life Course and Health (1)
  • Zika Virus (1)

Publication date

  • April 2023 (1)
  • March 2023 (1)
  • February 2023 (1)
  • October 2022 (1)
  • July 2022 (2)
  • May 2022 (2)
  • January 2022 (1)
  • November 2021 (1)
  • September 2021 (1)
  • May 2021 (1)
  • November 2020 (1)
  • June 2020 (1)
  • March 2020 (1)
  • January 2020 (1)
  • December 2019 (2)
  • November 2019 (1)
  • September 2019 (1)
  • May 2019 (1)
  • April 2019 (1)
  • March 2019 (1)
  • December 2018 (1)
  • September 2018 (2)
  • June 2018 (1)
  • May 2017 (1)
  • January 2015 (1)

From 1 October 2023, heel prick test also screens for metabolic disorder ALD

From 1 October 2023, the blood of newborn babies will also be tested for the metabolic disorder adrenoleukodystrophy (ALD). This is done with the heel prick screening test.
18-04-2023 | 08:40

NIPT available as standard option for all pregnant women from 1 April

From 1 April 2023, the Non-Invasive Prenatal Test (NIPT) will be available to all pregnant women. They do not have to take part in a scientific study for this.
27-03-2023 | 08:55
Arts overleg met toekomstige ouders

Provisional figures on participation in the National Immunisation Programme

According to RIVM’s registration system, at least 90% of babies have been vaccinated against mumps, measles and rubella (MMR).

02-02-2023 | 11:00
baby en peuter

Cancer screening programmes now more accessible to transgender and intersex persons

Since October 2022, is it has become easier for transgender and intersex persons to take part in cervical cancer screening and breast cancer screening. Transgender and intersex persons with a uterus and/or breast tissue can register with Bevolkingsonderzoek Nederland.
11-10-2022 | 17:22
Transgender symbool

Side effect reports National Immunisation Programme 2021

Last year, the Netherlands Pharmacovigilance Centre Lareb received 1,462 reports of possible side effects from vaccines administered under the National Immunisation Programme. As was the case in previous years, no new, disconcerting side effects have
25-07-2022 | 17:10
Meisje vier jaar

Participation in National Immunisation Programme shows slight decrease

Participation in the National Immunisation Programme has fallen slightly, showing a decrease of 1 to 2 percentage points.

04-07-2022 | 12:30
Rijksvaccinatie voorkant rapport

From 1 June 2022, heel prick test also screens for muscle disease SMA, bringing number of screened diseases to 26

From 1 June 2022, the heel prick test for Dutch newborns will also screen for spinal muscular atrophy (SMA). SMA is a serious hereditary muscle condition. Detecting this disease at an early stage enables early treatment.
20-05-2022 | 11:39

Tailor-made information will help immigrants make decisions on taking part in screening programmes

Immigrants are relatively less likely to take part in preventive screening programmes, such as cancer screening. This is partly due to the language barrier and a lack of knowledge, according to a doctoral thesis by Nora Hamdiui.
13-05-2022 | 10:03
Vier vrouwen op een pleintje

RIVM expands HPV vaccination programme: girls and boys protected from six types of cancer with one vaccine

Now not only girls, but also boys will have the opportunity to protect themselves from cancer caused by HPV.
31-01-2022 | 14:58
Jongen en meisjes poseren op een kruk voor campagneposter HPV vaccin

The National Immunisation Programme: the number of disease notifications decreased substantially in 2020

In 2020, fewer people fell ill from a disease against which vaccination is included in the National Immunisation Programme than in 2019. This is most likely due to coronavirus measures, such as social distancing, handwashing, and travel restrictions.
24-11-2021 | 22:45

Pagination

  • Current page 1
  • Page 2
  • Page 3
  • › Next ›
  • » Last »

Share this page


  • Facebook
  • Twitter
  • LinkedIn
  • WhatsApp
  • Email

Service

  • Contact
  • Information for the press
  • Working for RIVM
  • Complaints
  • Submitting WOO requests to RIVM
  • Doing business with RIVM

About this site

  • Cookies
  • Privacy
  • Accessibility
  • Copyright
  • Responsible disclosure
  • Website archive

Languages

  • English
  • Nederlands

Follow us

  • RIVM Newsletters
  • RSS reed
  • Twitter
  • Facebook
  • LinkedIn
  • Youtube
  • Instagram